Literatus: Active ingredient in green tea helps curb obesity

Zosimo T. Literatus
·2 min read

OBESITY is a metabolic disease. This means that obesity is a result of a disruption of the normal process of converting food into energy in the body at the level of the cells. The organs that process carbohydrates, fats and proteins simply have ceased to be as robust as when we were younger.

As a result, an abnormal increase in the accumulation of body occurs.

Socioeconomically, obesity is a result of eating more than the body needs in terms of physical activity. People who are not very active physically should be those who eat less.

However, saying so will be minding others’ business. So here we go.

The Philippines is not as poor a country as some media want us to believe. Clinically, though, obesity is observed when the fat cells in the body increase in reproduction in terms of number (hyperplasia) or cell size (hypertrophy). When this happens, complications also appear, such as diabetes, high blood pressure, and an abnormal level of fatty substances (lipid) in the blood.

Researchers Jim Ouyang, Kun Zhu, Zhonghua Liu and Jianan Huang from the Hunan Agricultural University in Changsha, China reported in Oxidative Medicine and Cellular Longevity journal (2020 issue) that Epigallocatechin-3-gallate (EGCG), the active ingredient found in green tea, can reduce the number of preadipocytes by up to 30 percent.

Preadipocytes are premature forms of fat cells (adipocytes), which later mature into adipocytes.

Meanwhile, the green tea referred to here are not those placed in tea bags. They must be fresh ones and directly mixed in hot water. The mixture is to be taken with all the undissolved tea granules.

EGCG appeared to suppress the process of synthesizing glucose from non-carbohydrate sources (e.g. proteins) and the process of fat formation (adipogenesis). It also increases the breakdown of fats in the body. This results in a decline in the human body weight, which corrects the existing metabolic syndrome, a spectrum of metabolic diseases (e.g. hypertension, heart disease and type-2 diabetes).

If you need more information, you can email me for a primer on EGCG studies on its use against obesity. I can also help you access reliable sources of these products.

Like the EGCG and uterine myoma primer, this primer will include toxicity findings so you will be forewarned on doses that should be avoided, based on research reports.